$1.30
6.56% today
Nasdaq, Aug 25, 09:14 pm CET
ISIN
US29405E1091
Symbol
ENVB

Enveric Biosciences Inc Stock price

$1.22
-0.19 13.48% 1M
-0.15 10.95% 6M
-4.16 77.31% YTD
-6.75 84.69% 1Y
-92.68 98.70% 3Y
-4,258.78 99.97% 5Y
-338,248.78 100.00% 10Y
-9.35 88.46% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.06 5.01%
ISIN
US29405E1091
Symbol
ENVB
Industry

Key metrics

Basic
Market capitalization
$4.0m
Enterprise Value
$-330.0k
Net debt
positive
Cash
$4.3m
Shares outstanding
2.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.0
P/B
1.0
Financial Health
Equity Ratio
51.7%
Return on Equity
-600.8%
ROCE
-238.4%
ROIC
-23,379.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-9.0m | $-6.1m
EBIT
$-9.3m | $-10.1m
Net Income
$-9.3m | $-2.2m
Free Cash Flow
$-7.5m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
34.3% | 34.1%
EBIT
33.6% | -4.9%
Net Income
38.5% | 77.3%
Free Cash Flow
34.9%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-5.2
FCF per Share
$-3.0
Short interest
10.4%
Employees
6
Rev per Employee
$0.0
Show more

Is Enveric Biosciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Enveric Biosciences Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Enveric Biosciences Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Enveric Biosciences Inc forecast:

Buy
86%
Hold
14%

Financial data from Enveric Biosciences Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 5.88 5.88
27% 27%
-
- Research and Development Expense 3.13 3.13
45% 45%
-
-9.02 -9.02
34% 34%
-
- Depreciation and Amortization 0.33 0.33
6% 6%
-
EBIT (Operating Income) EBIT -9.34 -9.34
34% 34%
-
Net Profit -9.30 -9.30
38% 38%
-

In millions USD.

Don't miss a Thing! We will send you all news about Enveric Biosciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Enveric Biosciences Inc Stock News

Neutral
Business Wire
11 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced financial results for the second quarter ended June 30, 2025, and provided a comprehensive business update. CEO Commentary “The second quarter of 2...
Neutral
Business Wire
about one month ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced a second Notice of Allowance from the United States Patent and Trademark Office (USPTO) for novel compounds within its EVM401 Series, expanding i...
Neutral
Business Wire
about one month ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of psychiatric and neurological disorders, today announced positive results in a preclinical, exposure-based therapeutic model for post-traumatic stress disorder (PTSD). In...
More Enveric Biosciences Inc News

Company Profile

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.

Head office United States
CEO Joseph Tucker
Employees 6
Founded 1994
Website www.enveric.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today